Answers are grounded in this paper and cite their sources.
These findings suggest that a raised serum GGT level is an independent risk factor for NIDDM. Serum GGT level may be a simple and reliable marker of visceral and hepatic fat and, by inference, of hepatic insulin resistance.
No takes yet. Share an insight, caveat, or question.
Perry et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: